ED, US Business Development and Licensing, Commercial Mergers & Integrations

The Executive Director, US Business Development and Licensing (BD&L), Commercial Mergers and Integrations (CMI) will partner with an extended team of US experts to develop strategic US assessments of potential assets and companies being evaluated by C&BD (Corporate and Business Development), ensuring the success of the US organization. Aligned cross‑functional assessments will be provided to the C&BD team for inclusion in the global deal assessments. This lead preserves the value of late‑stage M&A deals through immediate activation of the Novartis General Management organization and Launch Excellence teams. They drive rapid integration into Novartis business with a focus on activation of cross‑functional stakeholders, clear transition of deal case principles, valuation, strategic rationale, opportunities and risks for acquired assets. Leveraging the existing Blueprint, they engage and hold teams accountable to ensure US ownership of commercialization, maintaining momentum and preserving deal value. The role directly leads a team and collaborates with a large cross‑functional team across all pillars of the organization. She/He is the primary point of contact for the Strategy & Growth (S&G) team and the Corporate Integration Office, liaising with US teams and communicating progress on BD&L/CMI projects with US leadership, including the Business Leadership Team (BLT) and Therapeutic Area Heads (TAH). The role is based in our East Hanover, NJ office. Key Responsibilities Lead a team of two directors and cross‑functional teams to co‑develop business cases for potential assets and companies being evaluated, ensuring a unified US voice and securing USLT endorsement of recommendations. Provide a bridge between the General Management of acquired companies and their lead assets to accelerate Novartis commercial ownership and decision making. Deploy the established BD&L and CMI blueprints to ensure consistency and quality. Leverage TargetCo Virtual Data Rooms to inform BD&L and CMI deal assessments. Assess commercial readiness of TargetCo immediately after deal signing. Collaborate across US line functions to ensure go‑to‑market, access, M&S and other assumptions, and inputs into business cases are aligned, delivering a unified strategic assessment of BD&L/M&A targets. Assess business cases and scenarios regarding potential divestment, out‑licensing or co‑promoting of Novartis US established medicines. Drive organizational design for launch preparation of acquired assets, secure resourcing and approval for new organizations from US and International leadership (e.g., IPST in the US, equivalent internationally) until the final organization is in place, including asset(s) GM(s). Ensure inclusion in Launch / Business review governance as soon as feasible post‑deal close. Enable critical decision‑making impacting business readiness by NVS functional owners through transitional commercial governance, including working alliances and decision‑making structures with TargetCo. Manage the hybrid state of co‑existence between Novartis and the acquired company until full NVS commercial take‑over. Facilitate, measure and course‑correct matrix work with US General Management, S&G, CIO, and Development. Essential Requirements Bachelor’s Degree required; MBA, PharmD or Health Policy Degree preferred. 10+ years of relevant pharmaceutical industry experience (e.g., commercial, BD&L, insights and analytics, modelling, finance). Commercial experience and strong understanding of US commercialization/launch, including go‑to‑market models, coverage, reimbursement integration points, and marketing and sales requirements. Experience in BD&L or M&A or equivalent. Demonstrated experience establishing relationships and building networks across the research‑development‑commercial continuum. Deep knowledge of ways of working across the organization matrix; proven ability to influence stakeholders across functions. Strong people‑management skills with a track record of building and leading both individuals and cross‑functional teams. Excellent leadership presence and presentation skills. The salary for this position is expected to range between $248,500.00 and $461,500.00 per year. The final salary offered will be determined based on relevant skills, experience, and upon joining Novartis will be reviewed periodically. Novartis may change the published salary range based on company and market factors. Compensation will include a performance‑based cash incentive and, depending on the level of the role, eligibility to be considered for annual equity awards. US‑based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits. Employees are also eligible for a generous time‑off package, including vacation, personal days, holidays and other leaves. To learn more about the culture, rewards and benefits we offer our people. #J-18808-Ljbffr Novartis Farmacéutica